These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9452270)

  • 1. Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma.
    Wagatsuma S; Konno R; Sato S; Yajima A
    Cancer; 1998 Feb; 82(3):520-30. PubMed ID: 9452270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis and Bcl-2 protein expression in patients with endometrial carcinoma.
    Mazurek A; Pierzynski P; Niklinska W; Chyczewski L; Laudanski T
    Neoplasma; 2002; 49(3):149-54. PubMed ID: 12097999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis in endometrial carcinoma.
    Kaku T; Kamura T; Kinukawa N; Kobayashi H; Sakai K; Tsuruchi N; Saito T; Kawauchi S; Tsuneyoshi M; Nakano H
    Cancer; 1997 Aug; 80(4):741-7. PubMed ID: 9264358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of expression of interleukin-8 related to myometrial invasion with angiogenesis in uterine endometrial cancers.
    Fujimoto J; Aoki I; Khatun S; Toyoki H; Tamaya T
    Ann Oncol; 2002 Mar; 13(3):430-4. PubMed ID: 11996475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis, p53, and bcl-2 expression as prognostic indicators in endometrial cancer: comparison with traditional clinicopathologic variables.
    Erdem O; Erdem M; Dursun A; Akyol G; Erdem A
    Int J Gynecol Pathol; 2003 Jul; 22(3):254-60. PubMed ID: 12819392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormality of the hepatocyte growth factor/MET pathway in pulmonary adenocarcinogenesis.
    Tachibana K; Minami Y; Shiba-Ishii A; Kano J; Nakazato Y; Sato Y; Goya T; Noguchi M
    Lung Cancer; 2012 Feb; 75(2):181-8. PubMed ID: 21872356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan.
    Chen YS; Wang JT; Chang YF; Liu BY; Wang YP; Sun A; Chiang CP
    J Oral Pathol Med; 2004 Apr; 33(4):209-17. PubMed ID: 15061708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis in endometrial carcinoma: correlation with survival and clinicopathologic risk factors.
    Ozuysal S; Bilgin T; Ozan H; Kara HF; Oztürk H; Ercan I
    Gynecol Obstet Invest; 2003; 55(3):173-7. PubMed ID: 12865598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral angiogenesis: a new prognostic indicator for stage I endometrial adenocarcinomas?
    Giatromanolaki A; Sivridis E; Koukourakis MI; Georgoulias V; Gatter KC; Harris AL
    Oncol Res; 1999; 11(4):205-12. PubMed ID: 10566619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: a population-based endometrial carcinoma study.
    Salvesen HB; Iversen OE; Akslen LA
    J Clin Oncol; 1999 May; 17(5):1382-90. PubMed ID: 10334522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
    Fine BA; Valente PT; Feinstein GI; Dey T
    Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial carcinoma: association of steroid hormone receptor expression with low angiogenesis and bcl-2 expression.
    Sivridis E; Giatromanolaki A; Koukourakis M; Anastasiadis P
    Virchows Arch; 2001 May; 438(5):470-7. PubMed ID: 11407475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD105 expression is an independent predictor of survival in patients with endometrial cancer.
    Erdem O; Taskiran C; Onan MA; Erdem M; Guner H; Ataoglu O
    Gynecol Oncol; 2006 Dec; 103(3):1007-11. PubMed ID: 16854456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of ezrin, HGF and c-met and its clinicopathological significance in the benign and malignant lesions of the gallbladder.
    Yang L; Guo T; Jiang S; Yang Z
    Hepatogastroenterology; 2012 Sep; 59(118):1769-75. PubMed ID: 22172411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis of endometrial carcinomas assessed by measurement of intratumoral blood flow, microvessel density, and vascular endothelial growth factor levels.
    Lee CN; Cheng WF; Chen CA; Chu JS; Hsieh CY; Hsieh FJ
    Obstet Gynecol; 2000 Oct; 96(4):615-21. PubMed ID: 11004369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microvessel density (MVD) as a prognosticator in endometrial carcinoma.
    Ozalp S; Yalcin OT; Acikalin M; Tanir HM; Oner U; Akkoyunlu A
    Eur J Gynaecol Oncol; 2003; 24(3-4):305-8. PubMed ID: 12807245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Met in esophageal squamous cell carcinoma: an independent prognostic factor and potential therapeutic target.
    Ozawa Y; Nakamura Y; Fujishima F; Felizola SJ; Takeda K; Okamoto H; Ito K; Ishida H; Konno T; Kamei T; Miyata G; Ohuchi N; Sasano H
    BMC Cancer; 2015 Jun; 15():451. PubMed ID: 26036285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte growth factor (HGF) induces invasion of endometrial carcinoma cell lines in vitro.
    Bae-Jump V; Segreti EM; Vandermolen D; Kauma S
    Gynecol Oncol; 1999 May; 73(2):265-72. PubMed ID: 10329045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study on VEGF expression in endometrial carcinoma--comparison with p53 expression, angiogenesis, and tumor histologic grade.
    Fujisawa T; Watanabe J; Akaboshi M; Ohno E; Kuramoto H
    J Cancer Res Clin Oncol; 2001 Nov; 127(11):668-74. PubMed ID: 11710596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of basic fibroblastic growth factor and microvessel density in endometrial carcinoma].
    Bai X; Mi R
    Zhonghua Fu Chan Ke Za Zhi; 2000 Jun; 35(6):348-51. PubMed ID: 11776176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.